Dementia

Neurology·MeSH: Dementia

Prevalence

5.0 / 100K

41 drugs in development·25 companies·32 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
donepezil	DR REDDYS LABORATORIES LTD (RDY)
Kisunla	ELI LILLY & Co (LLY)
memantine	DR REDDYS LABORATORIES LTD (RDY)
namzaric	Adamas Pharmaceuticals Inc (ADMS)

Phase 3(7)

Drug	Company
AL050	Alector, Inc. (ALEC)
ANAVEX®2-73	ANAVEX LIFE SCIENCES CORP. (AVXL)
avp-786	NYMOX PHARMACEUTICAL CORP (NYMXF)
AXS-05	Axsome Therapeutics, Inc. (AXSM)
Latozinemab (AL001)	Alector, Inc. (ALEC)
Open label - AL001	Alector, Inc. (ALEC)
otl-204	Orchard Therapeutics plc (ORTX)

Phase 2(15)

Drug	Company
ACP-204	ACADIA PHARMACEUTICALS INC (ACAD)
AL001	Alector, Inc. (ALEC)
ANAVEX® 2-73 (blarcamesine)	ANAVEX LIFE SCIENCES CORP. (AVXL)
ANAVEX® 3-71 (AF710B)	ANAVEX LIFE SCIENCES CORP. (AVXL)
ct1812	COGNITION THERAPEUTICS INC (CGTX)
cvl-871	AbbVie Inc. (ABBV)
cvl-871	Cerevel Therapeutics Holdings, Inc. (CERE)
DNL593	Denali Therapeutics Inc. (DNLI)
ITI-1284-ODT-SL	Intra-Cellular Therapies, Inc. (ITCI)
mk-1167	Neuphoria Therapeutics Inc. (NEUP)
neflamapimod	CervoMed Inc. (CRVO)
nyx-458	Aptinyx Inc. (APTX)
sabirnetug (ACU193)	Acumen Pharmaceuticals, Inc. (ABOS)
zervimesine	COGNITION THERAPEUTICS INC (CGTX)
zervimesine (CT1812)	COGNITION THERAPEUTICS INC (CGTX)

Phase 1(6)

Drug	Company
ANAVEX®3-71	ANAVEX LIFE SCIENCES CORP. (AVXL)
ANVS301	Annovis Bio, Inc. (ANVS)
LY3884963	ELI LILLY & Co (LLY)
Optional Sirolimus	ELI LILLY & Co (LLY)
ov350	Ovid Therapeutics Inc. (OVID)
Sirolimus	ELI LILLY & Co (LLY)

Preclinical(5)

Phase 1/Phase 2(4)

Drug	Company
ly3884963	Prevail Therapeutics Inc. (PRVL)
optional sirolimus	Prevail Therapeutics Inc. (PRVL)
pbft02	Passage BIO, Inc. (PASG)
pr006	Prevail Therapeutics Inc. (PRVL)

BioSniper tracks 41 drugs in development for Dementia across 25 companies.

There are 32 clinical trials targeting Dementia tracked by BioSniper.

The estimated prevalence of Dementia is approximately 5.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.